DE60022011T2 - Immunstimulierende bakterienwandfraktionen zur krebsbehandlung - Google Patents

Immunstimulierende bakterienwandfraktionen zur krebsbehandlung Download PDF

Info

Publication number
DE60022011T2
DE60022011T2 DE60022011T DE60022011T DE60022011T2 DE 60022011 T2 DE60022011 T2 DE 60022011T2 DE 60022011 T DE60022011 T DE 60022011T DE 60022011 T DE60022011 T DE 60022011T DE 60022011 T2 DE60022011 T2 DE 60022011T2
Authority
DE
Germany
Prior art keywords
cancer treatment
bacterial wall
wall fractions
immunostimulating
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60022011T
Other languages
German (de)
English (en)
Other versions
DE60022011D1 (de
Inventor
Christine Libon
Nathalie Corvaia
Alain Beck
Jean-Yves Bonnefoy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Application granted granted Critical
Publication of DE60022011D1 publication Critical patent/DE60022011D1/de
Publication of DE60022011T2 publication Critical patent/DE60022011T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DE60022011T 1999-03-15 2000-03-15 Immunstimulierende bakterienwandfraktionen zur krebsbehandlung Expired - Lifetime DE60022011T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9903154A FR2790960B1 (fr) 1999-03-15 1999-03-15 Utilisation de fractions membranaires bacteriennes a activite immunostimulante dans le traitement de cancers, leurs procedes de preparation et les compositions pharmaceutiques les contenant
PCT/FR2000/000623 WO2000054790A1 (fr) 1999-03-15 2000-03-15 Fractions membranaires bacteriennes immunostimulantes dans le traitement de cancers

Publications (2)

Publication Number Publication Date
DE60022011D1 DE60022011D1 (de) 2005-09-22
DE60022011T2 true DE60022011T2 (de) 2006-06-14

Family

ID=9543185

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60022011T Expired - Lifetime DE60022011T2 (de) 1999-03-15 2000-03-15 Immunstimulierende bakterienwandfraktionen zur krebsbehandlung

Country Status (14)

Country Link
US (1) US7033591B1 (enExample)
EP (1) EP1161250B9 (enExample)
JP (1) JP2002539170A (enExample)
CN (1) CN1202127C (enExample)
AT (1) ATE302014T1 (enExample)
AU (1) AU776350B2 (enExample)
BR (1) BR0009052A (enExample)
CA (1) CA2367211A1 (enExample)
DE (1) DE60022011T2 (enExample)
DK (1) DK1161250T3 (enExample)
ES (1) ES2246831T3 (enExample)
FR (1) FR2790960B1 (enExample)
WO (1) WO2000054790A1 (enExample)
ZA (1) ZA200107368B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2808445A1 (fr) * 2000-05-04 2001-11-09 Pf Medicament Proteine omp associee a un lysat de cellules tumorales autologues et/ou heterologues
FR2809014A1 (fr) * 2000-05-16 2001-11-23 Pf Medicament Utilisation d'une proteine ompa d'enterobacterie comme agent antimicrobien
GB2370838A (en) 2001-01-06 2002-07-10 Benedikt Timmerman Immunogenic complex
FR2822071B1 (fr) * 2001-03-15 2005-07-01 Pf Medicament Utilisation d'une fraction membranaire de bacteries a gram negatif pour induire la maturation des cellules dendritiques
BR112016012127A2 (pt) * 2013-11-26 2017-09-26 Zoetis Services Llc composições para a indução da resposta imunológica
GB201713975D0 (en) * 2017-08-31 2017-10-18 Macrophage Pharma Ltd Medical use
CN113727722A (zh) * 2019-02-22 2021-11-30 伊夫罗生物科学公司 细菌膜制剂
EP4190894A1 (en) 2021-12-03 2023-06-07 CiMaas B.V. Method for the production of mature dendritic cells in vitro using a bacterial lysate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471785A1 (fr) * 1979-12-21 1981-06-26 Fabre Sa Pierre Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
FR2523154A1 (fr) * 1982-03-09 1983-09-16 Fabre Sa Pierre Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant
FR2596064B1 (fr) * 1986-03-18 1990-02-02 Pf Medicament Procedes industriels de fabrication de vaccins ribosomaux et vaccins ribosomaux obtenus
EP0268640A4 (en) * 1986-05-07 1989-11-30 Sloan Kettering Inst Cancer Vaccine for stimulating or enhancing production of antibodies directed against gm2.
WO1991012813A1 (en) * 1990-03-02 1991-09-05 Catherine Anne Mccall Method for treating cancer using combination chemotherapy and brm
US5242806A (en) * 1990-05-07 1993-09-07 Baxter Diagnostics Inc. Method for conducting the cytotoxicity assays on tumor cells
US5776898A (en) * 1991-05-14 1998-07-07 Dana-Farber Cancer Institute Method for treating a tumor with a chemotherapeutic agent
US5830686A (en) * 1994-01-13 1998-11-03 Calydon Tissue-specific enhancer active in prostate
FR2726472B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
FR2785542B1 (fr) * 1998-11-06 2001-02-09 Pf Medicament UTILISATION D'UNE PROTEINE OmpA D'ENTEROBACTERIE, POUR LE CIBLAGE SPECIFIQUE D'UNE SUBSTANCE BIOLOGIQUEMENT ACTIVE QUI LUI EST ASSOCIEE VERS LES CELLULES PRESENTATRICES D'ANTIGENES TELLES QUE LES CELLULES DENDRITIQUES HUMAINES

Also Published As

Publication number Publication date
FR2790960A1 (fr) 2000-09-22
DK1161250T3 (da) 2005-12-12
ZA200107368B (en) 2002-06-26
EP1161250A1 (fr) 2001-12-12
CN1202127C (zh) 2005-05-18
ATE302014T1 (de) 2005-09-15
JP2002539170A (ja) 2002-11-19
AU3298100A (en) 2000-10-04
CA2367211A1 (fr) 2000-09-21
WO2000054790A1 (fr) 2000-09-21
EP1161250B9 (fr) 2006-07-05
EP1161250B1 (fr) 2005-08-17
AU776350B2 (en) 2004-09-02
BR0009052A (pt) 2001-12-26
US7033591B1 (en) 2006-04-25
DE60022011D1 (de) 2005-09-22
CN1343125A (zh) 2002-04-03
ES2246831T3 (es) 2006-03-01
FR2790960B1 (fr) 2002-10-31

Similar Documents

Publication Publication Date Title
MX2025003080A (es) Conjugados de il-15, y sus usos
SG157951A1 (en) Cripto blocking antibodies and uses thereof
BG102708A (en) 4-aminopyrimidine derivatives, medicamentous preparations containing them, their application and method for their preparation
MXPA06001134A (es) Inhibidores de la actividad de la proteina cinasa b.
WO2004018000A3 (en) Compositions and methods for treating cancer using maytansinoid cd44 antibody immonoconjugates and chemotherapeutic agents
MY125202A (en) Vaccine
HUP0400231A3 (en) Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
IL146125A0 (en) Novel quinones as disease therapies
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
WO2005046579A3 (en) Defined dose therapeutic phage
DE60022011D1 (de) Immunstimulierende bakterienwandfraktionen zur krebsbehandlung
ATE233571T1 (de) Immunadsorber zur sepsistherapie
TW200600091A (en) Sulfonylethyl phosphorodiamidates
MXPA05009480A (es) Metodos y composiciones para la sintesis enzimatica de gangliosidos.
NZ542328A (en) Use of immune stimulating complex (ISCOM) particles as an adjuvant for an antigenic composition that comprises live micro organisms
CA2131565A1 (en) Organopolysiloxanes Containing Hydrophilic Groups
AU4414400A (en) Lactic acid bacteria with anxiolytic properties and uses thereof
BR0012973A (pt) Bifidobactérias capazes de prevenir diarréia
AU2001233912A1 (en) Diagnosis of breast cancer using bcmp-81 as marker
ZA991410B (en) Compounds and methods for the treatment of bacterial dysentry using antibiotics and toxin binding oligosaccharide compositions.
ATE346602T1 (de) Bakterienwandfraktionen mit adjuvansaktivität
AU2003230228A1 (en) Immunomodulating composition comprising a particulate fraction of bacterial mechanical lysates
WO2002057281A3 (en) Aminoglycosides as antibiotics
MX9802809A (es) Ureasa para el tratamiento de infecciones de helicobacter pylori.
UA29496C2 (uk) Ротор для перемішуючих пристроїв

Legal Events

Date Code Title Description
8364 No opposition during term of opposition